• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Temporary hold of mycophenolate augments humoral response to SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal diseases: a case series.

作者信息

Connolly Caoilfhionn M, Chiang Teresa Po-Yu, Boyarsky Brian J, Ruddy Jake A, Teles Mayan, Alejo Jennifer L, Massie Allan, Werbel William A, Shah Ami A, Christopher-Stine Lisa, Garonzik-Wang Jacqueline, Segev Dorry L, Paik Julie J

机构信息

Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA.

Surgery, Johns Hopkins University, Baltimore, Maryland, USA.

出版信息

Ann Rheum Dis. 2022 Feb;81(2):293-295. doi: 10.1136/annrheumdis-2021-221252. Epub 2021 Sep 23.

DOI:10.1136/annrheumdis-2021-221252
PMID:34556484
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11034709/
Abstract
摘要

相似文献

1
Temporary hold of mycophenolate augments humoral response to SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal diseases: a case series.霉酚酸临时停药增强风湿性和肌肉骨骼疾病患者对SARS-CoV-2疫苗的体液免疫反应：病例系列
Ann Rheum Dis. 2022 Feb;81(2):293-295. doi: 10.1136/annrheumdis-2021-221252. Epub 2021 Sep 23.
2
Absence of Humoral Response After Two-Dose SARS-CoV-2 Messenger RNA Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: A Case Series.风湿性和肌肉骨骼疾病患者接种两剂严重急性呼吸综合征冠状病毒2信使核糖核酸疫苗后无体液免疫反应：病例系列
Ann Intern Med. 2021 Sep;174(9):1332-1334. doi: 10.7326/M21-1451. Epub 2021 May 25.
3
Risk and prognosis of SARS-CoV-2 infection and vaccination against SARS-CoV-2 in rheumatic and musculoskeletal diseases: a systematic literature review to inform EULAR recommendations.风湿与肌肉骨骼疾病患者感染 SARS-CoV-2 及接种 SARS-CoV-2 疫苗的风险和预后：一项系统文献综述，旨在为 EULAR 建议提供信息。
Ann Rheum Dis. 2022 Mar;81(3):422-432. doi: 10.1136/annrheumdis-2021-221575. Epub 2021 Dec 7.
4
SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response.利妥昔单抗治疗患者的新型冠状病毒2型疫苗接种：体液免疫受损但细胞免疫反应可诱导的证据
Ann Rheum Dis. 2021 Oct;80(10):1355-1356. doi: 10.1136/annrheumdis-2021-220408. Epub 2021 May 6.
5
Humoral Immune Response to SARS-CoV-2 Vaccines in Patients with Autoimmune Rheumatic Diseases.自身免疫性风湿病患者对SARS-CoV-2疫苗的体液免疫反应
Arch Med Res. 2025 Apr;56(3):103141. doi: 10.1016/j.arcmed.2024.103141. Epub 2025 Jan 6.
6
Booster-dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series.自身免疫性疾病患者的新冠病毒加强剂量疫苗接种：病例系列
Ann Rheum Dis. 2022 Feb;81(2):291-293. doi: 10.1136/annrheumdis-2021-221206. Epub 2021 Sep 7.
7
A prospective multicenter study assessing humoral immunogenicity and safety of the mRNA SARS-CoV-2 vaccines in Greek patients with systemic autoimmune and autoinflammatory rheumatic diseases.一项评估 mRNA SARS-CoV-2 疫苗在希腊患有系统性自身免疫和自身炎症性风湿性疾病的患者中的体液免疫原性和安全性的前瞻性多中心研究。
J Autoimmun. 2021 Dec;125:102743. doi: 10.1016/j.jaut.2021.102743. Epub 2021 Oct 28.
8
Rituximab, but not other antirheumatic therapies, is associated with impaired serological response to SARS- CoV-2 vaccination in patients with rheumatic diseases.利妥昔单抗而非其他抗风湿疗法，与风湿性疾病患者对SARS-CoV-2疫苗的血清学反应受损有关。
Ann Rheum Dis. 2021 Oct;80(10):1357-1359. doi: 10.1136/annrheumdis-2021-220604. Epub 2021 May 11.
9
SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists.风湿性和肌肉骨骼疾病患者对新型冠状病毒2型疫苗的犹豫态度：给风湿病学家的启示
Ann Rheum Dis. 2021 Jul;80(7):953-954. doi: 10.1136/annrheumdis-2021-220059. Epub 2021 Feb 23.
10
Cellular immune response to the anti-SARS-CoV-2 BNT162b2 mRNA vaccine in pediatric autoimmune inflammatory rheumatic disease patients and controls.儿童自身免疫性炎症性风湿病患者和对照者对抗 SARS-CoV-2 BNT162b2 mRNA 疫苗的细胞免疫反应。
Clin Exp Immunol. 2024 Jul 12;217(2):167-172. doi: 10.1093/cei/uxae044.

引用本文的文献

1
Mycophenolate Interruption Restores Anti-SARS-CoV-2 Vaccine Immunogenicity in Unresponsive Liver Transplant Recipients.霉酚酸中断可恢复无反应性肝移植受者对SARS-CoV-2疫苗的免疫原性。
Vaccines (Basel). 2023 Jun 27;11(7):1165. doi: 10.3390/vaccines11071165.
2
Immunologic Response to SARS-CoV-2 Vaccination in Pediatric Kidney Transplant Recipients: A Systematic Review and Meta-Analysis.儿童肾移植受者对SARS-CoV-2疫苗接种的免疫反应：一项系统评价和荟萃分析。
Vaccines (Basel). 2023 Jun 9;11(6):1080. doi: 10.3390/vaccines11061080.
3
Perspectives on Mycophenolate Mofetil in the Management of Autoimmunity.霉酚酸酯在自身免疫性疾病治疗中的应用前景
Clin Rev Allergy Immunol. 2023 Aug;65(1):86-100. doi: 10.1007/s12016-023-08963-3. Epub 2023 Jun 20.
4
Managing Immunosuppression in Vasculitis Patients in Times of Coronavirus Disease 2019.COVID-19 时期血管炎患者的免疫抑制管理。
Rheum Dis Clin North Am. 2023 Aug;49(3):695-711. doi: 10.1016/j.rdc.2023.03.007. Epub 2023 Mar 14.
5
Efficacy and safety of mRNA and AstraZeneca COVID-19 vaccines in patients with autoimmune rheumatic diseases: A systematic review.mRNA 和阿斯利康 COVID-19 疫苗在自身免疫性风湿病患者中的疗效和安全性：一项系统评价。
Vaccine. 2023 Jun 13;41(26):3801-3812. doi: 10.1016/j.vaccine.2023.05.048. Epub 2023 May 22.
6
COVID-19 Prevention in Solid Organ Transplant Recipients: Current State of the Evidence.实体器官移植受者的 COVID-19 预防：现有证据状况。
Infect Dis Clin North Am. 2023 Sep;37(3):459-473. doi: 10.1016/j.idc.2023.03.002. Epub 2023 Mar 22.
7
What has vaccination against COVID-19 in CKD patients taught us?接种 COVID-19 疫苗对慢性肾脏病患者有何启示？
J Nephrol. 2023 Jun;36(5):1257-1266. doi: 10.1007/s40620-023-01640-w. Epub 2023 May 4.
8
Vaccines and therapeutics for immunocompromised patients with COVID-19.针对新冠病毒免疫功能低下患者的疫苗和治疗方法。
EClinicalMedicine. 2023 May;59:101965. doi: 10.1016/j.eclinm.2023.101965. Epub 2023 Apr 12.
9
Persistent SARS-CoV-2-specific immune defects in kidney transplant recipients following third mRNA vaccine dose.肾移植受者接种第三剂 mRNA 疫苗后持续存在的 SARS-CoV-2 特异性免疫缺陷。
Am J Transplant. 2023 Jun;23(6):744-758. doi: 10.1016/j.ajt.2023.03.014. Epub 2023 Mar 24.
10
Impact of immunosuppressive treatment and type of SARS-CoV-2 vaccine on antibody levels after three vaccinations in patients with chronic kidney disease or kidney replacement therapy.免疫抑制治疗和新型冠状病毒2型疫苗类型对慢性肾脏病或肾脏替代治疗患者三次接种疫苗后抗体水平的影响
Clin Kidney J. 2022 Nov 24;16(3):528-540. doi: 10.1093/ckj/sfac249. eCollection 2023 Mar.

本文引用的文献

1
American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 2.美国风湿病学会关于风湿和肌肉骨骼疾病患者 COVID-19 疫苗接种的指南：第 2 版。
Arthritis Rheumatol. 2021 Aug;73(8):e30-e45. doi: 10.1002/art.41877. Epub 2021 Jun 15.
2
High antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with rheumatic and musculoskeletal diseases.风湿性和肌肉骨骼疾病患者对两剂严重急性呼吸综合征冠状病毒2信使核糖核酸疫苗的高抗体反应。
Ann Rheum Dis. 2021 Oct;80(10):1351-1352. doi: 10.1136/annrheumdis-2021-220656. Epub 2021 May 24.
3
Absence of Humoral Response After Two-Dose SARS-CoV-2 Messenger RNA Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: A Case Series.风湿性和肌肉骨骼疾病患者接种两剂严重急性呼吸综合征冠状病毒2信使核糖核酸疫苗后无体液免疫反应：病例系列
Ann Intern Med. 2021 Sep;174(9):1332-1334. doi: 10.7326/M21-1451. Epub 2021 May 25.
4
Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients.实体器官移植受者对两剂严重急性呼吸综合征冠状病毒2信使核糖核酸疫苗系列的抗体反应。
JAMA. 2021 Jun 1;325(21):2204-2206. doi: 10.1001/jama.2021.7489.
5
Quantitative Measurement of Anti-SARS-CoV-2 Antibodies: Analytical and Clinical Evaluation.抗SARS-CoV-2抗体的定量检测：分析与临床评估
J Clin Microbiol. 2021 Mar 19;59(4). doi: 10.1128/JCM.03149-20.